STOCK TITAN

ELI LILLY & Co (LLY) SEC Filings, Jul-Aug 2025

LLY NYSE
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
insider
-
Rhea-AI Summary

Eli Lilly & Co. (LLY) filed a Form 144 notice for the proposed sale of restricted shares.

  • Seller intends to dispose of 280,000 common shares through Fidelity Capital Markets.
  • At the filing’s reference price, the block is worth $223.7 million.
  • Eli Lilly has 947.7 million shares outstanding, so the sale represents roughly 0.03 % of the float—small in relation to daily liquidity and unlikely to be dilutive.
  • Planned trade date: 24 Jul 2025; exchanges listed: NYSE / NASDAQ.
  • The shares trace back to a 10 Feb 1948 gift from the J.K. Lilly Sr. Trust; no other sales were reported in the past three months.

The filer certifies awareness of no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many ELI LILLY & Co (LLY) SEC filings are available on StockTitan?

StockTitan tracks 215 SEC filings for ELI LILLY & Co (LLY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ELI LILLY & Co (LLY)?

The most recent SEC filing for ELI LILLY & Co (LLY) was filed on August 4, 2025.